EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 (EUCRU)

CUSIP: G3141W114

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / UNIT 10/23/2027
Total 13F shares
8,490,544
Share change
+7,854,208
Total reported value
$90,392,000
Price per share
$10.66
Number of holders
37
Value change
+$83,608,000
Number of buys
33

Quarterly Holders Quick Answers

What is CUSIP G3141W114?
CUSIP G3141W114 identifies EUCRU - EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 (EUCRU) as of Q4 2020

As of 31 Dec 2020, EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 (EUCRU) was held by 37 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,490,544 shares. The largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, 683 Capital Management, LLC, Magnetar Financial LLC, BVF INC/IL, Altium Capital Management LP, CVI Holdings, LLC, Sio Capital Management, LLC, and Schonfeld Strategic Advisors LLC. This page lists 37 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.